Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Rotavapor® R-210/R-215

Product Image
Product Description

The Rotavapors R-210/215 can be used for all kind of applications in different kind of laboratories. It not only combines maximum safety for the user but also for the product. The complete solution with vacuum controller, vacuum pump and recirculating chiller allows you to evaporate your solvents in the most efficient and gentle way.

The Rotavapor R-210/215 features the following advantages:

•    Maximum safety for the user and the product
•    Complete solution with vacuum controller, vacuum pump and recirculating chiller
•    Long-life seals provide practically maintenance-free operation and increase service life
•    A wide range of glass assemblies covers numerous applications
•    Compact assembly with small footprint
•    Wireless contacts on the heating bath for both power supply and communications
•    Proven BUCHI quality

Product Rotavapor® R-210/R-215
Company BUCHI Labortechnik AG
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BUCHI Labortechnik AG
Meierseggstrasse 40 Postfach CH-9230 Flawil 1 Switzerland

Tel: +41 71 394 63 63
Fax: +41 71 394 64 64
Email: buchi@buchi.com



Scientific News
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
`Molecular Commando’ Identified to Tackle Hypoxia Pathway
Scientists identify 'molecular commando' that can activate hypoxic response, which helps combat a number of conditions.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Two Antibiotics Fight Bacteria Differently Than Thought
Researchers discover that two widely prescribed antibiotics may fight bacteria differently than previously thought.
Drug Target for Gastrointestinal Stromal Tumors Identified
Researchers show the Hedgehog signaling pathway is central to the formation of gastrointestinal stromal tumors.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!